Dashboard
1
Poor Management Efficiency with a low ROCE of 8.61%
- The company has been able to generate a Return on Capital Employed (avg) of 8.61% signifying low profitability per unit of total capital (equity and debt)
2
High Debt Company with a Debt to Equity ratio (avg) at times
3
Poor long term growth as Net Sales has grown by an annual rate of -4.10% and Operating profit at -149.53% over the last 5 years
4
With a fall in Net Sales of -15.88%, the company declared Very Negative results in Mar 25
5
Risky -
Stock DNA
Pharmaceuticals & Biotechnology
CNY 507 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.56
-0.31%
0.58
Revenue and Profits:
Net Sales:
140 Million
(Quarterly Results - Jun 2025)
Net Profit:
-9 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.5%
0%
0.5%
6 Months
7.43%
0%
7.43%
1 Year
28.05%
0%
28.05%
2 Years
-32.56%
0%
-32.56%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Jiangsu Topfly New Materials Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-4.10%
EBIT Growth (5y)
-149.53%
EBIT to Interest (avg)
32.12
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.53
Sales to Capital Employed (avg)
0.83
Tax Ratio
4.57%
Dividend Payout Ratio
55.99%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.61%
ROE (avg)
6.45%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.58
EV to EBIT
-1.37
EV to EBITDA
6.66
EV to Capital Employed
0.05
EV to Sales
0.03
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3.41%
ROE (Latest)
-0.31%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
140.40
166.90
-15.88%
Operating Profit (PBDIT) excl Other Income
-7.50
7.20
-204.17%
Interest
0.20
0.20
Exceptional Items
0.00
-0.10
100.00%
Consolidate Net Profit
-9.00
6.60
-236.36%
Operating Profit Margin (Excl OI)
-82.80%
21.30%
-10.41%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is -15.88% vs -13.30% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is -236.36% vs -63.93% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
639.40
713.20
-10.35%
Operating Profit (PBDIT) excl Other Income
22.40
55.80
-59.86%
Interest
1.10
1.30
-15.38%
Exceptional Items
0.00
-1.10
100.00%
Consolidate Net Profit
18.60
44.30
-58.01%
Operating Profit Margin (Excl OI)
11.60%
55.50%
-4.39%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -10.35% vs -11.15% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -58.01% vs -40.54% in Dec 2023
About Jiangsu Topfly New Materials Co., Ltd. 
Jiangsu Topfly New Materials Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






